These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18489439)

  • 1. Molecular modeling and docking analysis of Entamoeba histolytica glyceraldehyde-3 phosphate dehydrogenase, a potential target enzyme for anti-protozoal drug development.
    Singh S; Malik BK; Sharma DK
    Chem Biol Drug Des; 2008 Jun; 71(6):554-62. PubMed ID: 18489439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: implications for structure-based drug design.
    Kundu S; Roy D
    J Biomol Struct Dyn; 2007 Aug; 25(1):25-33. PubMed ID: 17676935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
    Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
    J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
    Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
    Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure.
    Kim H; Hol WG
    J Mol Biol; 1998 Apr; 278(1):5-11. PubMed ID: 9571030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Entamoeba histolytica: ADP-ribosylation of secreted glyceraldehyde-3-phosphate dehydrogenase.
    Alvarez AH; Martinez-Cadena G; Silva ME; Saavedra E; Avila EE
    Exp Parasitol; 2007 Dec; 117(4):349-56. PubMed ID: 17586498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi.
    de Marchi AA; Castilho MS; Nascimento PG; Archanjo FC; del Ponte G; Oliva G; Pupo MT
    Bioorg Med Chem; 2004 Sep; 12(18):4823-33. PubMed ID: 15336261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entamoeba histolytica: computer-assisted modeling of phosphofructokinase for the prediction of broad-spectrum antiparasitic agents.
    Byington CL; Dunbrack RL; Whitby FG; Cohen FE; Agabian N
    Exp Parasitol; 1997 Nov; 87(3):194-202. PubMed ID: 9371084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
    Ismail SA; Park HW
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
    Guido RV; Oliva G; Montanari CA; Andricopulo AD
    J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of glyceraldehyde-3-phosphate dehydrogenase from Plasmodium falciparum at 2.25 A resolution reveals intriguing extra electron density in the active site.
    Robien MA; Bosch J; Buckner FS; Van Voorhis WC; Worthey EA; Myler P; Mehlin C; Boni EE; Kalyuzhniy O; Anderson L; Lauricella A; Gulde S; Luft JR; DeTitta G; Caruthers JM; Hodgson KO; Soltis M; Zucker F; Verlinde CL; Merritt EA; Schoenfeld LW; Hol WG
    Proteins; 2006 Mar; 62(3):570-7. PubMed ID: 16345073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening.
    Saucedo-Mendiola ML; Salas-Pacheco JM; Nájera H; Rojo-Domínguez A; Yépez-Mulia L; Avitia-Domínguez C; Téllez-Valencia A
    J Enzyme Inhib Med Chem; 2014 Jun; 29(3):325-32. PubMed ID: 23534932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of electronic and structural descriptors of adenosine analogues related to inhibition of leishmanial glyceraldehyde-3-phosphate dehydrogenase.
    Lozano NB; Oliveira RF; Weber KC; Honorio KM; Guido RV; Andricopulo AD; Da Silva AB
    Molecules; 2013 Apr; 18(5):5032-50. PubMed ID: 23629757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of
    Alves KMA; Cardoso FJB; Honorio KM; de Molfetta FA
    Med Chem; 2020; 16(6):784-795. PubMed ID: 31309897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
    Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
    Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A structural model for chorismate synthase from Mycobacterium tuberculosis in complex with coenzyme and substrate.
    Fernandes CL; Breda A; Santos DS; Basso LA; Souza ON
    Comput Biol Med; 2007 Feb; 37(2):149-58. PubMed ID: 16584721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycolysis in Entamoeba histolytica. Biochemical characterization of recombinant glycolytic enzymes and flux control analysis.
    Saavedra E; Encalada R; Pineda E; Jasso-Chávez R; Moreno-Sánchez R
    FEBS J; 2005 Apr; 272(7):1767-83. PubMed ID: 15794763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase.
    Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.